Cellectis S.A.

Approval AI-extracted

cema-cel

first-line consolidation for large B-cell lymphoma (LBCL)

Date

TBD

Approval decision · Date TBD estimated

What's at stake A final FDA approval decision on cema-cel for first-line consolidation for large B-cell lymphoma (LBCL) is expected Date TBD.

Primary source · SEC 6-K verified 12h ago

“If positive, Allogene announced that these results could support a BLA submission.”